日本フィジカルAI新聞

世界のフィジカルAIを、日本語で。

週刊ニュースレター購読
医用画像合成arXiv:2608.22828v1

VeCAS: 血管介入のための血管焦点型無造影剤血管造影合成

VeCAS: Vessel-Focused Contrast-Free Angiogram Synthesis for Vascular Interventions

シェア:XThreadsFacebookLINEはてブBluesky

非造影X線画像から血管造影画像を合成する2段階フレームワークを提案し、血管構造の局在化と造影外観の合成を分離することで、高品質な合成を実現した。

著者: De-Xing Huang, Chen-Yu Wang, Hao Liang, Xiao-Hu Zhou, Mei-Jiang Gui, Tian-Yu Xiang, Qin-Yi Zhang, Chen Wang, Xiao-Liang Xie, Shi-Qi Liu, Ming-Yuan Liu, Zhen-Chang Wang, Zeng-Guang Hou

分類: cs.CV

原文アブストラクト

X-ray angiography relies on iodinated contrast agents to visualize vascular structures during image-guided interventions. However, contrast administration carries risks of adverse events, motivating the development of contrast-free alternatives. Generating X-ray angiograms directly from non-contrast X-ray images offers a potential solution, but existing approaches remain limited by (i) insufficient control over vascular localization and (ii) inefficient modeling of redundant background content. To address these challenges, we propose VeCAS, a two-stage vessel-focused contrast-free angiogram synthesis framework that separates vascular structure localization from angiographic appearance synthesis. In Stage I, a discriminative model localizes vascular structures in non-contrast X-ray images, while cross-modality latent distillation transfers vessel-sensitive knowledge from X-ray angiograms during training. In Stage II, a vessel-focused inpainting model synthesizes angiographic appearance within the localized vascular regions while preserving the non-vascular background. Experiments on an in-house lower-limb vascular intervention dataset show that VeCAS outperforms the comparison methods in terms of vascular structural fidelity and image quality. Visual Turing tests and physician assessments indicate the perceptual realism of the synthesized angiograms. In addition, robotic guidewire navigation experiments in vascular phantoms show that VeCAS guidance reduces the time to target by 41.4% and the number of operation steps by 40.7% compared with non-contrast guidance. Together, these results suggest the potential of VeCAS to serve as ``meta contrast agent'' for vascular interventions.